Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FM888 capsule phase IIa trial in postherpetic neuralgia
CTR20240018Phase 2Active
- Sponsor
- Yongzhan Pharmaceutical Technology
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FM888 in postherpetic neuralgia (PHN), Neuralgia, sponsored by Yongzhan Pharmaceutical Technology. Started Jan 2024; status: active.
02
Drugs
FM888
03
Conditions
postherpetic neuralgia (PHN)Neuralgia
Beyond the preview
Go deeper on CTR20240018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240018.